EX-10.6






 Exhibit 10.6 

SECOND JOINDER AGREEMENT AND FOURTH AMENDMENT 

(New Term Loans) 
 SECOND
JOINDER AGREEMENT AND FOURTH AMENDMENT (this “Agreement”), dated as of September 21, 2020, by and among the New Term Loan Lender set forth on the signature pages hereto (the “New Term Loan Lender”), Aveanna
Healthcare LLC, a Delaware limited liability company (the “Borrower”), the other Credit Parties, Barclays Bank PLC, as the Administrative Agent (the “Administrative Agent”). 

RECITALS: 
 WHEREAS,
reference is hereby made to the First Lien Credit Agreement, dated as of March 16, 2017 (as amended by that certain Joinder Agreement and Amendment, dated as of July 1, 2018, Amendment No. 2 to First Lien Credit Agreement, dated
as of March 19, 2020, and Amendment No. 3 to First Lien Credit Agreement, dated as of April 1, 2020, and as further amended, restated, amended and restated, supplemented or otherwise modified from time to time, the “Credit
Agreement”), among Aveanna Healthcare Intermediate Holdings LLC (f/k/a BCPE Eagle Intermediate Holdings LLC), a Delaware limited liability company, the Borrower (f/k/a BCPE Eagle Buyer LLC), the lending institutions from time to time party
thereto, and Barclays Bank PLC, as the Administrative Agent, the Collateral Agent, a Letter of Credit Issuer, and a Lender (capitalized terms used but not defined herein having the meaning provided in the Credit Agreement); 

WHEREAS, subject to the terms and conditions of the Credit Agreement, the Borrower may establish New Term Loan Commitments by, among
other things, entering into one or more Joinder Agreements with New Term Loan Lender, as applicable; 
 WHEREAS, the Administrative
Agent and the Borrower may amend the Credit Agreement and the other Credit Documents without the consent of any other party as may be necessary or appropriate, in the reasonable opinion of the Administrative Agent and the Borrower, to effect the
terms of any incremental facility in accordance with Section 2.14 of the Credit Agreement; 
 WHEREAS, the
Borrower has requested that the New Term Loan Lender having the New Term Loan Commitments (as defined below) as set forth on Schedule 1 hereto provide $185,000,000 of New Term Loans to be drawn on the New Term Loan Closing Date (as defined below)
(the “New Term Loans”); 
 WHEREAS, the Borrower intends to use the proceeds of the New Term Loans, and cash on
hand, if any, to (i) fund the acquisition by the Borrower, directly or indirectly, of all of the outstanding equity interests of D&D Services, Inc. d/b/a Preferred Pediatric Home Health Care (the “Preferred Acquisition”)
pursuant to that certain Stock Purchase Agreement, dated as of August 13, 2020, by and among the Borrower, D&D Services, Inc. and the sellers party thereto (together with the schedules and exhibits thereto, the “Preferred
Acquisition Agreement”), (ii) fund the acquisition by the Borrower of Evergreen Home Healthcare, LLC (the “Evergreen Acquisition”) pursuant to that certain Membership Interest Purchase Agreement, dated as of August 12,
2020, by and among Pediatric Services of America, Inc., Evergreen Home Healthcare, LLC and the sellers party thereto (together with the schedules and exhibits thereto, the “Evergreen Acquisition Agreement”), (iii) fund the
acquisition by the Borrower of Five Points Healthcare, LLC (“Five Points Acquisition”) pursuant to that certain Member Interest Purchase Agreement dated September 17, 2020, by and among Aveanna Healthcare Senior Services, LLC,
Five Points Healthcare, LLC and the sellers party thereto (together with the schedules and exhibits thereto, 













 
the “Five Points Acquisition Agreement”), (iv) repay outstanding Revolving Credit Loans (without a corresponding commitment reduction), (v) fund working capital and general
corporate purposes (including to consummate any other Permitted Acquisitions) and (vi) pay fees, premiums and expenses incurred in connection with the foregoing and the consummation of any other transaction contemplated herein (the “New
Term Loan Transactions”, and the fees and expenses related to the foregoing, the “New Term Loan Transaction Costs”); and 

WHEREAS, each of Barclays Bank PLC, BMO Capital Markets Corp. and Jefferies Capital Services LLC (collectively, the “New Term
Loan Lead Arrangers”) has agreed to act as a lead arranger and joint bookrunner for the New Term Loans; 
 NOW, THEREFORE,
in consideration of the premises and agreements, provisions and covenants herein contained, the parties hereto agree as follows: 
 The New
Term Loan Lender party hereto hereby commits to provide its New Term Loan Commitment for the New Term Loan (the “New Term Loan Commitments”) as set forth on Schedule 1 annexed hereto, on the terms and subject to the
conditions set forth below. 
 1.    Funding. The New Term Loan Lender hereby agrees (a) with respect to its
New Term Loan Commitments, to make New Term Loans denominated in Dollars to the Borrower in a single draw on the New Term Loan Closing Date, which New Term Loans shall not exceed for such Lender the New Term Loan Commitments of such Lender. New Term
Loans that are repaid or prepaid may not be reborrowed. 
 2.    Applicable Margin. The Applicable Margin for ABR
Loans or for LIBOR Loans, as applicable, for each New Term Loan shall mean, as of any date of determination, the applicable percentage per annum as set forth below; provided, that (i) notwithstanding anything to the contrary in the
definition of “LIBOR Rate” in the Credit Agreement, in no event shall the LIBOR Rate applicable to the New Term Loans at any time be less than 1.00% per annum, and (ii) notwithstanding anything to the contrary in the definition of
“ABR” in the Credit Agreement, in no event shall the ABR applicable to the New Term Loans at any time be less than 2.00% per annum. 
  

			
	 New Term Loans

	 LIBOR Loans
	  	 ABR Loans

	 6.25%
	  	5.25%

 3.    Principal Payments. The New Term Loan Maturity Date for the New Term Loans
shall be the Initial Term Loan Maturity Date. The Borrower shall repay to the Administrative Agent on the last Business Day of each March, June, September and December, commencing with the last Business Day of the first full fiscal quarter ending
after the New Term Loan Closing Date and ending with the last such Business Day prior to the Initial Term Loan Maturity Date, for the benefit of the New Term Loan Lender, a principal amount equal to 0.25% of the aggregate principal amount of all New
Term Loans outstanding on the New Term Loan Closing Date (which amounts shall be reduced by the amount of the relevant scheduled principal payments that have been prepaid or deemed prepaid in accordance with the Credit Agreement, including as set
forth in Section 5.1, Section 5.2(c) and Section 13.6(h) of the Credit Agreement). 

  
 2 















	 	4.	 Voluntary and Mandatory Prepayments. 



(a)    Scheduled installments of principal of the New Term Loans set forth above shall be reduced in connection with any
voluntary or mandatory prepayments of the New Term Loans in accordance with Section 5.1, Section 5.2 or Section 13.6(h) of the Credit Agreement, as applicable. 

(b)    To the extent that the Evergreen Acquisition is not consummated on or prior to October 31, 2020 (as may be
extended pursuant to the terms the Evergreen Acquisition Agreement), the Borrower shall prepay Term Loans on a pro rata basis in accordance with Section 5.2(c) in an amount equal to $15,000,000. 

(c)    To the extent that the Five Points Acquisition is not consummated by the termination date under the Five Points
Acquisition Agreement (as may be extended pursuant to the terms thereof), the Borrower shall prepay Term Loans on a pro rata basis in accordance with Section 5.2(c) in an amount equal to $20,000,000. 

5.    MFN Adjustment. With respect to any New Term Loans (as defined in the Credit Agreement) made under New Term
Loan Commitments (as defined in the Credit Agreement), which are committed to by Lenders after the date hereof (such New Term Loans, the “Post-Amendment Term Loans”) (other than those incurred pursuant to clause (i) of the
definition of “Maximum Incremental Facilities Amount”), and that are pari passu in right of payment with the New Term Loans incurred under this Agreement prior to the date that is twelve (12) months after the New Term Loan
Closing Date and not incurred in connection with a Permitted Acquisition if the Effective Yield for LIBOR Loans in respect of any Post-Amendment Term Loans that rank pari passu in right of payment and security with the New Term Loans as of
the date of funding thereof exceeds the Effective Yield for LIBOR Loans in respect of the New Term Loans hereunder by more than 0.50%, the Applicable Margin for LIBOR Loans in respect of such New Term Loans hereunder shall be adjusted so that the
Effective Yield in respect of such New Term Loans is equal to the Effective Yield for LIBOR Loans in respect of such Post-Amendment Term Loans minus 0.50%; provided, further, to the extent any change in the Effective Yield of the New
Term Loans is necessitated by this Section 5 on the basis of an effective interest rate floor in respect of the Post- Amendment Term Loans, the increased Effective Yield in the New Term Loans shall (unless otherwise agreed in writing by the
Borrower) have such increase in the Effective Yield effected solely by increases in the interest rate floor(s) applicable to the New Term Loans. 

6.    Use of Proceeds. The proceeds of the New Term Loans will be applied on the New Term Loan Closing Date,
together with cash on the balance sheet of Holdings and its Subsidiaries (if any), (i) to consummate the Preferred Acquisition, the Evergreen Acquisition, and the Five Points Acquisition, (ii) to repay outstanding Revolving Credit Loans
(without a permanent commitment reduction), (iii) for working capital and general corporate purposes (including to any other Permitted Acquisitions) and (iv) to pay the New Term Loan Transaction Costs. 

7.    Prepayment Premium. In the event that, prior to the twelve-month anniversary of the New Term Loan Closing
Date, the Borrower (i) makes any prepayment of the New Term Loans in connection with any Repricing Transaction the primary purpose of which is to decrease the Effective Yield on such New Term Loans or (ii) effects any amendment of the
Credit Agreement resulting in a Repricing Transaction the primary purpose of which is to decrease the Effective Yield on the New Term Loans, the Borrower shall pay to the Administrative Agent, for the ratable account of each of the applicable
Lenders, (x) in the case of clause (i), a prepayment premium of 1.00% of the principal amount of the New Term Loans being prepaid in connection with such Repricing Transaction and (y) in the case of clause (ii), an amount equal to 1.00% of
the aggregate principal amount of the applicable New Term Loans outstanding immediately prior to such amendment that are subject to an effective pricing reduction pursuant to such Repricing Transaction. For purposes of this
Section 7, references in the definition of “Repricing Transaction” in the Credit Agreement to the “Initial Term Loans” shall deemed to be references to the New Term Loans. 

  
 3 














 8.    Proposed Initial Borrowing. This Agreement represents a
request by the Borrower to borrow the New Term Loans from the New Term Loan Lender as follows (the “Proposed Initial Borrowing”): 

(a)    Business Day of Proposed Initial Borrowing: September 21, 2020 

(b)    Amount of Proposed Initial Borrowing: $185,000,000 

(c)    Interest rate option: 

(i)    $185,000,000 of LIBOR Loans with an initial Interest Period ending on December 31, 2020. 

(d)    The New Term Loans borrowed pursuant to this notice shall be disbursed in accordance with the Funds Flow to be
dated September 21, 2020. 
 9.    New Term Loan Lender. To the extent not already a Lender, the New Term
Loan Lender party hereto acknowledges and agrees that upon its execution of this Agreement and the making of New Term Loans, as the case may be, that such New Term Loan Lender shall become a “Lender” under, and for all purposes of,
the Credit Agreement and the other Credit Documents, and shall be subject to and bound by the terms thereof, and shall perform all the obligations of and shall have all rights of a Lender thereunder and under the Intercreditor Agreements, as
applicable, pursuant to Section 12.13 of the Credit Agreement. The New Term Loan Lender (i) confirms that it has received a copy of the Credit Agreement and the other Credit Documents and the exhibits thereto, together
with copies of the most recent financial statements referred to in Section 8.9 of the Credit Agreement or delivered pursuant to Section 9.1 of the Credit Agreement, as applicable, and such other
documents and information as it has deemed appropriate to make its own credit analysis and decision to enter into this Agreement; (ii) agrees that it will, independently and without reliance upon the Administrative Agent, the Collateral Agent
or any other Lender or Agent, and based on such documents and information as it shall deem appropriate at the time, continue to make its own credit decisions in taking or not taking action under the Credit Agreement; (iii) appoints and
authorizes the Administrative Agent and the Collateral Agent to take such action as agent on its behalf and to exercise such powers under the Credit Agreement and the other Credit Documents as are delegated to the Administrative Agent or the
Collateral Agent, as the case may be, by the terms thereof, together with such powers as are reasonably incidental thereto; and (iv) agrees that it will perform in accordance with their terms all of the obligations which by the terms of the
Credit Documents are required to be performed by it as a Lender. 
 10.    Credit Agreement Governs. Except as
set forth in this Agreement, the New Term Loans shall otherwise be subject to the provisions of the Credit Agreement and the other Credit Documents. 

  
 4 















	 	11.	 Conditions Precedent. 



(a)    New Term Loan Closing Date Conditions. The Borrowing of the New Term Loan on September 21, 2020 (the
“New Term Loan Closing Date”) is subject solely to the satisfaction or waiver by the New Term Loan Lead Arrangers of the following conditions precedent: 

(i)    The Preferred Acquisition shall have been, or substantially concurrently with the initial borrowing
of the New Term Loan shall be, consummated in all material respects in accordance with the Preferred Acquisition Agreement. No provision of the Preferred Acquisition Agreement shall have been waived, amended, consented to or otherwise modified by
the Borrower in a manner material and adverse to the New Term Loan Lender (in their respective capacities as such) without the consent of the New Term Loan Lead Arrangers (not to be unreasonably withheld, delayed, denied or conditioned);
provided that (i) any reduction in the purchase price for the Preferred Acquisition set forth in the Preferred Acquisition Agreement shall not be deemed to be material and adverse to the interests of the New Term Loan Lender so long as
(except in the case of any such decrease (x) pursuant to any purchase price or similar adjustment provisions set forth in the Preferred Acquisition Agreement, (y) that, excluding the amount of any such purchase price or similar adjustment,
is less than ten percent (10%) of the total Preferred Acquisition consideration, which in the case of clauses (x) and/or (y) shall not be considered material and adverse to the interests of the New Term Loan Lenders) any such reduction is
applied to reduce the New Term Loans to be funded on the New Term Loan Closing Date on a dollar-for-dollar basis, (ii) any increase in the purchase price set forth in
the Preferred Acquisition Agreement shall be deemed to be not material and adverse to the interests of the New Term Loan Lender so long as such purchase price increase is not funded with additional Indebtedness of the Borrower or its Restricted
Subsidiaries, other than amounts permitted to be drawn under the Revolving Credit Facility (it being understood and agreed that no purchase price, working capital or similar adjustment provisions set forth in the Preferred Acquisition Agreement
shall constitute a reduction or increase in the purchase price) and (iii) any change to the definition of Material Adverse Effect (as defined in the Preferred Acquisition Agreement) shall be deemed materially adverse to the New Term Loan Lender
and shall require the consent of the New Term Loan Lead Arrangers (not to be unreasonably withheld, delayed, denied or conditioned). 

(ii)    The New Term Loan Lead Arrangers shall have received an unaudited pro forma consolidated
capitalization table and related unaudited pro forma consolidated adjusted EBITDA of the Borrower and its subsidiaries as of and for the twelve-month period ending on June 30, 2020, prepared after giving effect to the New Term Loan Transactions
to occur on the New Term Loan Closing Date, the Evergreen Acquisition and the Five Points Acquisition had occurred on such date (which need not be prepared in compliance with Regulations S-X of the Securities
Act of 1933, as amended, or include adjustments for purchase accounting (including adjustments of the type contemplated by Financial Accounting Standards Board Accounting Standards Codification 805, Business Combinations (formerly SFAS 141R))). The
New Term Loan Lead Arrangers shall also have received quality of earnings report for Preferred and its Subsidiaries, Evergreen and its Subsidiaries and Five Points and its Subsidiaries. 

(iii)    The Administrative Agent shall have received (at least three (3) Business Days prior to the
New Term Loan Closing Date) all documentation and other information about each Credit Party as has been reasonably requested in writing at least ten (10) Business Days prior to the New Term Loan Closing Date by the Administrative Agent or the
New Term Loan Lead Arrangers that is required by regulatory authorities under applicable “know your customer” and anti-money laundering rules and regulations, including without limitation the PATRIOT Act and a certification regarding
beneficial ownership. 
 (iv)    The Administrative Agent (or its counsel) shall have received this
Agreement, executed and delivered by a duly Authorized Officer of each Credit Party. 
 (v)    The
Administrative Agent (or its counsel) shall have received (x) executed legal opinions, in customary form, from (i) Kirkland & Ellis LLP, as New York counsel to the Credit 

  
 5 














 Parties, (ii) Greenberg Traurig LLP, as special Delaware, Pennsylvania, Massachusetts,
Nevada, New Jersey, Arizona, Colorado, Virginia and Georgia counsel to the Credit Parties, (iii) Polsinelli PC, as special Washington and Missouri counsel to the Credit Parties, (iv) Dickinson Wright PLLC, as special Michigan counsel to
the Credit Parties and (v) Nelson Mullins Riley & Scarborough LLP as special North Carolina counsel to the Credit Parties, (y) a customary certificate of each Credit Party, dated the New Term Loan Closing Date, substantially in
the form delivered on the Closing Date, with appropriate insertions and attaching (i) a copy of the resolutions of the applicable governing body of each Credit Party (or a duly authorized committee thereof) authorizing (a) the execution,
delivery, and performance of this Agreement and any related agreements to which it is a party and (b) in the case of the Borrower, the extensions of credit contemplated hereunder, (ii) the applicable Organizational Documents of each of
each Credit Party (or confirming no amendment to such Organizational Documents have been made with respect to such Credit Party since such Organizational Documents were delivered to the Administrative Agent in connection with that certain Joinder
Agreement and Amendment, dated July 1, 2018) and, to the extent applicable in the jurisdiction of organization of such Credit Party, a certificate as to its good standing as of a recent date from an applicable Governmental Authority in such
jurisdiction of organization, and (iii) signature and incumbency certificates (or other comparable documents evidencing the same) of the Authorized Officers of each Credit Party executing this Agreement and any related agreements to which it is
a party (or confirming there are no such changes to the Authorized Officers with respect to such Credit Party since the Closing Date), and (z) a certificate dated the New Term Loan Closing Date and signed by an Authorized Officer of the
Borrower, certifying (i) that the New Loan Commitments do not exceed the Maximum Incremental Facilities Amount (it being understood that the Borrower has made an LCT Election with respect to the New Term Loan Transactions, the Evergreen
Acquisition, and the Five Points Acquisition and that the LCT Test Date shall be the execution date of the Preferred Acquisition Agreement, the Evergreen Acquisition Agreement or the Five Points Acquisition Agreement, as applicable) and (ii) as
to compliance with the condition set forth in clause (ix) below. The Borrower hereby instructs and agrees to instruct the other Credit Parties to have the counsel described in this clause (v) deliver such legal opinions. 

(vi)    On the New Term Loan Closing Date, the Administrative Agent shall have received a certificate from
the Chief Financial Officer of the Borrower (or other officer of the Borrower with similar responsibilities) substantially in the form of Exhibit A hereto to the effect that after giving effect to the consummation of the New Term Loan Transactions
to occur on the New Term Loan Closing Date, the Borrower, together with its Subsidiaries on a consolidated basis, is Solvent. 

(vii)    All fees required to be paid on the New Term Loan Closing Date pursuant to that certain Fee
Letter, dated as of September 8, 2020, by and among the Borrower, the New Term Loan Lead Arrangers and the other parties thereto, and reasonable and documented
out-of-pocket expenses previously agreed in writing to be paid on the New Term Loan Closing Date, in each case to the extent invoiced at least three (3) Business
Days prior to the New Term Loan Closing Date, shall have been paid, or shall be paid substantially concurrently with, the initial Borrowing hereunder (which amounts may, at the Borrower’s option, be offset against the proceeds of the New Term
Loans). 
 (viii)    There shall have been no event, circumstance, condition, change or effect that has
had, or would reasonably be expected to have, individually or in the aggregate, a Material Adverse Effect (as defined in the Preferred Acquisition Agreement). 

  
 6 














 (ix)    The Specified Representations shall be true and
correct in all material respects as of the New Term Loan Closing Date. Notwithstanding anything to the contrary contained herein, (w) to the extent any of the Specified Representations to be made on the New Term Loan Closing Date are qualified or
subject to “material adverse effect,” the definition thereof shall be “Material Adverse Effect” as defined in the Preferred Acquisition Agreement for purposes of such representations and warranties made or to be made on, or as
of, the New Term Loan Closing Date (x)the representations and warranties set forth in Section 8.2 of the Credit Agreement shall apply only with respect to organizational power and authority of the Credit Parties and due
authorization, execution and delivery by the Credit Parties, in each case, as they relate to their entry into and performance of, this Agreement, and enforceability of this Agreement against the Credit Parties, (y) the representations and warranties
set forth in Section 8.3(c) of the Credit Agreement shall apply only with respect to the Credit Parties as related to the entry into and performance by the Credit Parties of this Agreement and (z) the representations
and warranties set forth in Section 8.5 and Section 8.18 of the Credit Agreement shall apply only with respect to the New Term Loans. 

(x)    The representations and warranties made by or with respect to Preferred and its subsidiaries in the
Preferred Acquisition Agreement as are material to the interests of the Lenders, but only to the extent that the Borrower (or any of its Affiliates) have the right (taking into account any applicable cure provisions) to terminate its obligations
under the Preferred Acquisition Agreement or decline to consummate the Preferred Acquisition (in each case, in accordance with the terms of the Preferred Acquisition Agreement) as a result of a breach of such representations and warranties in the
Preferred Acquisition Agreement (the “Specified Preferred Acquisition Agreement Representations”), shall be true and correct in all material respects as of the New Term Loan Closing Date (or as of such earlier date if expressly made
as of such earlier date). Notwithstanding anything to the contrary contained herein, to the extent any of the Specified Preferred Acquisition Agreement Representations to be made on the New Term Loan Closing Date are qualified or subject to
“material adverse effect,” the definition thereof shall be “Material Adverse Effect” as defined in the Preferred Acquisition Agreement for purposes of such representations and warranties made or to be made on, or as of, the New
Term Loan Closing Date. Notwithstanding anything to the contrary contained herein, the conditions contained in the first sentence of clause(i), clause (viii) and this clause (x) shall, in each case, be governed by, and interpreted in
accordance with, the laws of the State of Delaware, regardless of the laws that might otherwise govern under applicable principles of conflicts of laws. 

(xi)    No Event of Default under Section 11.1 or
Section 11.5 of the Credit Agreement shall exist on the New Term Loan Closing Date or immediately after giving effect thereto. 

(b)    Additional Amendments Condition. Pursuant to the last paragraph of Section 13.1 of
the Credit Agreement which permits the Credit Agreement to be amended, supplemented or modified with the written consent of the Administrative Agent and the Borrower in a manner not materially adverse to any Lender (and the Administrative Agent and
the Borrower hereby acknowledge that such amendments are not materially adverse to any Lender), the amendments to the Credit Agreement set forth herein shall be effective as of the date hereof subject to the Administrative Agent’s (or its
counsel’s) receipt of this Agreement executed and delivered by a duly Authorized Officer of the Borrower and the Administrative Agent. 

12.    Reaffirmation of the Credit Parties. Each Credit Party hereby consents to the terms of this Agreement and
the amendment of the Credit Agreement effected hereby, including without limitation, the making of the New Term Loans. Each Credit Party hereby confirms that each Credit Document to which it is a party or otherwise bound and all Collateral
encumbered thereby will continue to guarantee or secure, as the case may be, to the fullest extent possible in accordance with the Credit Documents the 

  
 7 














 payment and performance of all “Obligations” under each of the Credit Documents to which it is a
party (in each case as such terms are defined in the applicable Credit Document), including without limitation, the New Term Loans. Each Credit Party acknowledges and agrees that any of the Credit Documents (as they may be modified by this
Agreement) to which it is a party or otherwise bound shall continue in full force and effect and that all of its obligations thereunder shall be valid and enforceable and shall not be impaired or limited by the execution or effectiveness of this
Agreement other than to the extent expressly contemplated hereby. 
 13.    Post-Closing Covenant. The Borrower
shall deliver, or cause to be delivered, to the Administrative Agent within 30 days of the New Term Loan Closing Date (or such later date as may be agreed to by the Administrative Agent in its in its reasonable discretion) a good standing
certificate in respect of Option 1 Nutrition Solutions CA, Inc. from the applicable Governmental Authority in such entity’s jurisdiction of organization. 

14.    Notice. For purposes of the Credit Agreement, to the extent not already a Lender, the initial notice address
of the New Term Loan Lender shall be as set forth below its signature below. 
 15.    Notice of Borrowing. The
notice in respect of any initial Borrowing under this Agreement may be conditioned on any Permitted Acquisition or other acquisition or Permitted Investment. 

16.    Acknowledgments. 

(a)    The Administrative Agent and the Borrower acknowledge that the amendments to the Credit Agreement contained in this
Agreement are necessary or appropriate to effect the terms of the New Term Loans. 
 (b)    All parties hereto
acknowledge that this Agreement constitutes (i) the requisite notice required by Section 2.14 of the Credit Agreement and (ii) a “Joinder Agreement.” 

17.    Tax Forms. For the New Term Loan Lender, delivered herewith to the Administrative Agent and the Borrower are
such forms, certificates or other evidence with respect to United States federal income tax withholding matters as the New Term Loan Lender may be required to deliver to the Administrative Agent and/or the Borrower pursuant to
Section 5.4(e) of the Credit Agreement. 
 18.    Recordation of the New Loans. Upon
execution and delivery hereof, the Administrative Agent will record the New Term Loans, as the case may be, made by the New Term Loan Lender in the Register. 

19.    Amendment, Modification and Waiver. This Agreement may not be amended, modified or waived except by an
instrument or instruments in writing with the consent of the Persons required to sign such instrument by Section 13.1 of the Credit Agreement. 

20.    Entire Agreement. This Agreement, the Credit Agreement and the other Credit Documents constitute the entire
agreement among the parties with respect to the subject matter hereof and thereof and supersede all other prior agreements and understandings, both written and verbal, among the parties or any of them with respect to the subject matter hereof. 

21.    GOVERNING LAW. THIS AGREEMENT AND THE RIGHTS AND OBLIGATIONS OF THE PARTIES HEREUNDER SHALL BE GOVERNED BY, AND
CONSTRUED AND INTERPRETED IN ACCORDANCE WITH, THE LAW OF THE STATE OF NEW YORK. 

  
 8 














 22.    Severability. Any provision of this Agreement that is
prohibited or unenforceable in any jurisdiction shall, as to such jurisdiction, be ineffective to the extent of such prohibition or unenforceability without invalidating the remaining provisions hereof, and any such prohibition or unenforceability
in any jurisdiction shall not invalidate or render unenforceable such provision in any other jurisdiction. 

23.    Counterparts. This Agreement may be executed by one or more of the parties to this Agreement on any number
of separate counterparts (including by facsimile or other electronic transmission), and all of said counterparts shall be deemed originals and taken together shall be deemed to constitute one and the same instrument. A set of the copies of this
Agreement signed by all the parties shall be lodged with the Borrower and the Administrative Agent. The words “execution,” “signed,” “signature,” and words of like import in this Agreement shall be deemed to include
electronic signatures or the keeping of electronic records in electronic form, each of which shall be of the same legal effect, validity or enforceability as a manually executed signature or the use of a paper-based recordkeeping system, as the case
may be, to the extent and as provided for in any applicable law, including the Federal Electronic Signatures in Global and National Commerce Act, the New York State Electronic Signatures and Records Act, or any other similar state laws based on the
Uniform Electronic Transactions Act. 
 [Signature Pages Follow] 

  
 9 














 IN WITNESS WHEREOF, each of the undersigned has caused its duly authorized officer to
execute and deliver this Agreement as of the date first set forth above. 
  

							
	BARCLAYS BANK PLC,
	as the Administrative Agent
			
		 	By:	 	 /s/ Ronnie Glenn

		 		 	Name:	 	Ronnie Glenn
		 		 	Title:	 	Director


 [Signature Page to Joinder Agreement and Amendment] 













 
							
	BARCLAYS BANK PLC,
	as the New Term Loan Lender
			
		 	By:	 	 /s/ Ronnie Glenn

		 		 	Name:	 	Ronnie Glenn
		 		 	Title:	 	Director


 [Signature Page to Joinder Agreement and Amendment] 













 IN WITNESS WHEREOF, each of the undersigned has caused its duly authorized officer to
execute and deliver this Agreement as of the date first set forth above. 
  

			
	AVEANNA HEALTHCARE LLC,
	as the Borrower
		
	By:	 	 /s/ David Afshar

	Name	 	David Afshar
	Title:	 	Chief Financial Officer


  

			
	AVEANNA HEALTHCARE INTERMEDIATE HOLDINGS LLC
	AB INNOVATIONS HEALTH SERVICES INCORPORATED
	AMERICAN STAFFING SERVICES, INC. ANDVENTURE, INC.
	ASSURE HOME HEALTHCARE, INC.
	CARE AMERICA HOME CARE SERVICES, INC.
	CARE UNLIMITED, INC.
	DAWSON THOMAS, INC.
	DM HOLDCO, INC.
	EHS DE HOLDINGS, INC.
	EPIC ACQUISITION, INC.
	EPIC HEALTH SERVICES, INC., a Delaware corporation
	EPIC HEALTH SERVICES, INC., a
	Massachusetts corporation
	EPIC HEALTH SERVICES, INC., a Texas corporation
	FHH HOLDINGS, INC.
	FIRSTAFF NURSING SERVICES, INC.
	FREEDOM ELDERCARE NY, INC.
	 FREEDOM HOME HEALTHCARE, INC.

LCA HOLDING, INC.

	LOVING CARE AGENCY, INC.
	MEDCO RESPIRATORY INSTRUMENTS, INCORPORATED
	OPTION 1 NUTRITION HOLDINGS, INC.
	OPTION 1 NUTRITION SOLUTIONS CA, INC PEDIATRIC HOME HEALTH CARE HOLDINGS, INC.


 Joinder Agreement and Amendment 













 
	
	PEDIATRIC SERVICES HOLDING CORPORATION
	PEDIATRIC SERVICES OF AMERICA, INC., Delaware corporation
	 PEDIATRIC SERVICES OF AMERICA, INC.,

Georgia corporation

	PEDIATRIC SPECIAL CARE, INC.
	PSA HEALTHCARE INTERMEDIATE
	HOLDING INC.
	REHABILITATION ASSOCIATES, INC.
	SANTÉ HOLDINGS, INC.
	EPIC HEALTH SERVICES (PA), LLC
	HOMEFIRST HEALTHCARE SERVICES, LLC
	PREMIER HEALTHCARE SERVICES, LLC
	TCG HOME HEALTH, LLC
	TCGHHA, LLC
	EPIC HEALTH SERVICES (DE), LLC
	EPIC PEDIATRIC THERAPY, L.P.
	JED ADAM ENTERPRISES, LLC
	PENNHURST GROUP, LLC
	PEDIATRIA HEALTHCARE LLC
	NURSES TO GO, L.L.C.
	OPTION 1 BILLING GROUP, LLC
	OPTION 1 NORTHWEST ENTERAL, LLC
	OPTION 1 NUTRITION SOLUTIONS, LLC, an Arizona limited liability company
	OPTION 1 NUTRITION SOLUTIONS, LLC, a
	Colorado limited liability company
	OPTION 1 NUTRITION GROUP, LLC
	PEDIATRIC HOME NURSING SERVICES, INC.
	PYRA MED HEALTH SERVICES, LLC
	SANTÉ GP, LLC
	CHILD’S PLAY THERAPEUTIC
	 HOMECARE, INC.
  

each as a Guarantor




 

			
	By:	 	 /s/ David Afshar

	Name:	 	David Afshar
	Title:	 	Chief Financial Officer


 Joinder Agreement and Amendment 













 SCHEDULE 1 

TO JOINDER AGREEMENT AND AMENDMENT 

Commitments of New Term Loan Lender 

New Term Loan Commitments 
  

					
	 Name of New Term Loan Lender
	  	New Term Loan Commitment	 
	 Barclays Bank PLC
	  	$	185,000,000	 
		  	  
	  
	 
	 Total:
	  	$	185,000,000	 
		  	  
	  
	 














 EXHIBIT A 

TO JOINDER AGREEMENT AND AMENDMENT 

Form of Solvency Certificate 

[DATE] 
 Pursuant to the Second Joinder Agreement
and Fourth Amendment, dated as of the date hereof, 2020 (the “Joinder Agreement”) to that certain First Lien Credit Agreement, dated as of March 16, 2017 (as amended, restated, supplemented, waived or otherwise modified from
time to time, the “Credit Agreement”), by and among Aveanna Healthcare Intermediate Holdings LLC, a Delaware limited liability company, Aveanna Healthcare LLC, a Delaware limited liability company (the
“Borrower”), the lending institutions from time to time parties hereto as lenders and Barclays Bank PLC, as the administrative agent, the collateral agent, a letter of credit issuer, the swingline lender and a lender, the
undersigned hereby certifies to the Administrative Agent and the Lenders, solely in such undersigned’s capacity as [chief financial officer] [chief operating officer] [specify other officer with similar responsibilities] of the Borrower, and
not individually (and without personal liability), as follows: 
 As of the date hereof, on a pro forma basis after giving effect to the consummation
of the transactions to occur on the date of the Joinder Agreement, including the making of the Loans under the Credit Agreement on the date hereof, and after giving effect to the application of the proceeds of such Loans: 

 

	 	(a)	 the fair value of the assets (on a going concern basis) of the Borrower and its Subsidiaries, on a consolidated
basis, exceeds, on a consolidated basis, their debts and liabilities, subordinated, contingent or otherwise; 


  

	 	(b)	 the present fair saleable value of the property (on a going concern basis) of the Borrower and its
Subsidiaries, on a consolidated basis, is greater than the amount that will be required to pay the probable liability, on a consolidated basis, of their debts and other liabilities, subordinated, contingent or otherwise, as such debts and other
liabilities become absolute and matured in the ordinary course of business; 


  

	 	(c)	 the Borrower and its Subsidiaries, on a consolidated basis, are able to pay their debts and liabilities,
subordinated, contingent or otherwise, as such liabilities become absolute and matured in the ordinary course of business; and 


  

	 	(d)	 the Borrower and its Subsidiaries, on a consolidated basis, are not engaged in, and are not about to engage in,
business contemplated as of the date hereof for which they have unreasonably small capital. 


 For purposes of this Solvency Certificate,
the amount of any contingent liability at any time shall be computed as the amount that would reasonably be expected to become an actual and matured liability in the ordinary course of business. Capitalized terms used but not otherwise defined
herein shall have the respective meanings assigned to them in the Credit Agreement. 
 The undersigned is familiar with the business and financial position
of the Borrower and its Subsidiaries (taken as a whole). In reaching the conclusions set forth in this Solvency Certificate, the undersigned has made such other investigations and inquiries as the undersigned has deemed appropriate, having taken
into account the nature of the particular business anticipated to be conducted by the Borrower and its Subsidiaries (taken as a whole) after consummation of the transactions contemplated by the Joinder Agreement. 













 [Signature Page Follows] 

  
 A–2 














 IN WITNESS WHEREOF, the undersigned has executed this Solvency Certificate in such
undersigned’s capacity as [chief financial officer][chief operating officer][specify other officer with similar responsibilities] of the Borrower, on behalf of the Borrower, and not individually, as of the date first stated above. 

 

			
	 AVEANNA HEALTHCARE LLC,

as the Borrower

		
	 By:
	 	
              
      

	 Name:
	 	  

	 Title:
	 	  




  
 A–3